surmount 1 tirzepatide Clinical Trials Orals Session ESC 2025: post-hoc SURMOUNT-5 data

Learn more about the side effects of Zepbound

Within the GLP-1 cohort, 76.4% were prescribed semaglutide, 18.1% dulaglutide, 5.1% liraglutide, 0.3% lixisenatide and 0.1% exenatide

What matters most is maintaining a consistent 7-day interval between injections

It provides a reliable, fast, and transparent way to handle every calculation from reconstitution to final dose measurement

How Your Genetics Influence GLP-1 Response Not everyone responds to GLP-1 medications the same way

This dual action potentially makes Tirzepatide more effective in promoting weight loss and improving metabolic health compared to medications that target only GLP-1 receptors